戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 ( right1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                                      Future studies will address the origin and potential mechanistic rol
2  the population level, carefully designed seroepidemiologic studies will aid in the characterization of transmission dyna
3                                             Together, these studies will aid in the synthesis of new beta-lactam antibiot
4                                                       These studies will aid the design of therapeutic strategies for can
5                                                     Further studies will be conducted to explore the potential of (68)Ga-
6 shed data about the issue, future multicenter international studies will be helpful.
7                                          Further functional studies will be important to assess the potential of LRRK2 mo
8                                      Longitudinal follow-up studies will be necessary to ascertain the long-term neurolog
9 ize individual SIM-SUMO complexes and suggests that further studies will be necessary to understand these interactions wh
10                                          Future mechanistic studies will be needed to determine the precise functional ef
11                                                      Future studies will be needed to quantify the clinical value of thes
12 ons has been established, a critical analysis of pioneering studies will be presented.
13 its limitations, knowing that further randomized controlled studies will be required before the approval of AI techniques
14 entricular tachycardia, although further large animal model studies will be required to control post-transplant arrhythmi
15                                                     Further studies will be required to define whether inter-individual v
16                                                     Further studies will be required to determine which of these genes, e
17                                                     Phase 3 studies will define the efficacy and safety profile further.
18                                                      Future studies will determine the mechanism(s) by which SA photoperi
19                                                      Future studies will determine whether these gRNA dynamics represent
20                                                      Future studies will determine whether this imbalance represents an e
21                                                      Future studies will determine whether this phenomenon represents an
22  Using our method to improve the resolution of fine-mapping studies will enable more efficient expenditure of resources i
23 on of metabolomics with the on-going genomic and phenotypic studies will enhance 'omics-wide associations of molecular si
24                                    Preclinical and clinical studies will examine the systemic effects of endurance and re
25                                Ongoing field and laboratory studies will facilitate better understanding of the potential
26                                                     Planned studies will fill many of the existing gaps in the literature
27                                                      Future studies will focus on optimization of these new anti-HCMV com
28                                                Many ongoing studies will further define the ideal combination and long-te
29                                                      Future studies will further elucidate the role of DSIF in transcript
30 nd its microenvironment, we surmise that single-cell-guided studies will help chart the spatiotemporal molecular and cell
31                                                       These studies will help develop animal models to more accurately re
32                                                       These studies will help guide the development of new photoactive ma
33 nclusion, this study shows that very large population-based studies will help refine our understanding of the pathogenici
34                              A larger cohort and functional studies will help validate the pathogenicity of the mutations
35                                                     Further studies will identify pathways that are associated with incre
36                            Furthermore, future longitudinal studies will increase our understanding of tau pathophysiolog
37 ant preclinical mouse models and human correlative research studies will inform development of the next stage of immune-b
38                                                      Future studies will investigate EMI-137 for improved colorectal poly
39                                       As the field matures, studies will move beyond descriptive characterizations toward
40                                                      Future studies will need to address technical challenges such as how
41                                                      Future studies will need to combine remote sensing with field-based
42                                                      Future studies will probe the nature of these compounds in inhibitin
43  to secure supply of low-cost vaccines, and ongoing vaccine studies will provide critical vaccine performance data and in
44 mitigated to an acceptable, very low, level and whether the studies will provide substantial benefits that could not read
45 ol use as proxy measures for AUD, and we outline how future studies will require careful phenotype harmonization to prope
46                                                      Future studies will shed light on discovering novel mechanisms of mu
47                             The use of DRAMS in multi-omics studies will strengthen statistical power of the study and im
48                                                      Future studies will utilize FAAH mutants of moss to elucidate the ro
49 s such as single-cell omics, in combination with functional studies, will be instrumental to uncover the remaining unknow
50 g data, and machine learning, as well as carefully designed studies, will help to identify and confirm potential biomarke